10-Q
Quarterly Report
Autonomix Medical, Inc.
AMIX
NASDAQ
CIK: 1617867
File #: 001-41940
Balance Sheet
28 line items · 2 periods
XBRL
| Item | Sep 30, 2024 | Mar 31, 2024 |
|---|---|---|
Current assets: | ||
Cash and cash equivalents | 5,155,000 | 8,608,000 |
Other current assets | 199,000 | 783,000 |
Total current assets | 5,354,000 | 9,391,000 |
Long term assets: | ||
Fixed assets, net | 17,000 | 16,000 |
Total long term assets | 17,000 | 16,000 |
Total Assets | 5,371,000 | 9,407,000 |
Current liabilities: | ||
Accounts payable | 574,000 | 492,000 |
Accrued expenses | 683,000 | 285,000 |
Total current liabilities | 1,257,000 | 777,000 |
Long term liabilities: | ||
Long term debt - convertible notes, net of unamortized debt discount | 1,086,000 | 1,002,000 |
The Notes - Convertible Debt | 1,086,000 | — |
Total long term liabilities | 1,086,000 | 1,002,000 |
Total Liabilities | 2,343,000 | 1,779,000 |
Stockholders' equity: | ||
Preferred stock, $0.001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of September 30, 2024 and March 31, 2024, respectively | 0 | 0 |
Common stock, $0.001 par value, 500,000,000 shares authorized, 1,152,120 and 942,575 shares issued and outstanding as of September 30, 2024 and March 31, 2024, respectively | 1,000 | 1,000 |
Additional paid-in capital | 47,502,000 | 46,596,000 |
Accumulated deficit | (44,475,000) | (38,969,000) |
Total Stockholders' Equity | 3,028,000 | 7,628,000 |
Preferred Stock | 0 | 0 |
Common Stock | 1,000 | 1,000 |
Additional Paid-in Capital | 47,502,000 | 46,596,000 |
Retained Earnings | (44,475,000) | (38,969,000) |
Total Liabilities and Stockholders' Equity | 5,371,000 | 9,407,000 |